Cue Biopharma, Inc. (CUE) AI Dilution Summary

Cash was $17,392,000 at 2026-06-30 against estimated monthly burn of $6,657,667, with the Jefferies LLC ATM (authorised to $80,000,000) as the funding channel: 450,866 shares sold since the program began through 2026-06-30, sales after 2026-06-30 not yet reported. The most recent raise was a private placement closed 2026-07-13, raising $49,800,000 net from 1,418,071 shares at $33.21 per share plus pre-funded warrants for 87,500 shares.